SMC unable to recommend use of fenticonazole (Ginoxin®) vaginal cream and capsules due to non-submission

Homepage

Search the NeLM

Medicines A-Z

Find key information about medicines by name (prototype)

Browse by Categories:

Browse by NeLM area:

SMC unable to recommend use of fenticonazole (Ginoxin®) vaginal cream and capsules due to non-submission

Source: Scottish Medicines Consortium (SMC)

Date published: 07/02/2011 16:11

Summary

by: Nicola Pocock

Due to the absence of a submission from the marketing authorisation holder, the Scottish Medicines Consortium (SMC) is unable to recommend fenticonazole (Ginoxin®) for use within NHS Scotland for the treatment of vulvovaginal candidiasis.

About this library entry

Category: 5.2 Antifungal drugs | Drug reviews | Fungal | Scottish Medicines Consortium

NeLM area: Evidence > Drug Specific Reviews

Link (drug advice)

Preview your comment

Add new comment

Comment text:

Comments

There are no comments yet. You could be the first! You must be Logged In to comment.

Printer Friendly Version

Related evidence

5.2 Antifungal drugs

08/02/2011

New CKS Topic: Breastfeeding problems

27/01/2010

Cochrane review: Oral potassium iodide for the treatment of sporotrichosis

22/09/2009

CKS Topic Minibite: Oral candida

Fungal

07/02/2011

SMC does not recommend use of buccal miconazole (Loramyc®) for oropharyngeal candidiasis

02/11/2010

New CKS Topic: Pityriasis versicolor

27/01/2010

Cochrane review: Oral potassium iodide for the treatment of sporotrichosis

Back